Baijayantimala Swain | Pharmaceutical Medicinal Chemistry Award | Best Researcher Award

Posted on by ScienceFather

Dr. Baijayantimala Swain | Pharmaceutical Medicinal Chemistry Award | Best Researcher Award

Dr. Baijayantimala Swain, bharat institute of technology- pharmacy, India

Dr. Baijayantimala Swain is an accomplished medicinal chemist with expertise in drug design and discovery, specializing in carbonic anhydrase inhibitors. With a Ph.D. from NIPER Hyderabad, she has synthesized novel compounds targeting various isoforms of carbonic anhydrase, crucial in diseases like cancer and glaucoma. 🧪 Her research has led to the development of potent molecules with therapeutic potential. Dr. Swain’s multidisciplinary skills encompass organic synthesis, analytical techniques, and computational chemistry. She is recognized for her contributions to scientific literature and holds a strong academic background, fostering collaborative research in pharmaceutical sciences. 🎓

 

Publication Profile

Scopus

Academic Qualification 

Dr. Baijayantimala Swain forged her path in pharmaceutical sciences. From her Bachelor’s in Pharmaceutical Sciences at Sri Jaydev College in Odisha, India 🎓, she ventured into deeper realms with a Master’s in Medicinal Chemistry at NIPER, Hyderabad, delving into the intricacies of peptide synthesis for anticancer endeavors. Driven by an insatiable thirst for knowledge, she pursued a Ph.D. in Medicinal Chemistry at the same institute, where she honed her skills in designing novel inhibitors for carbonic anhydrases, under the guidance of esteemed mentors. Each milestone illuminated her academic odyssey, shaping her into a versatile researcher.

 

Research Focus 🧪

Dr. Baijayantimala Swain’s research primarily revolves around the design and synthesis of novel compounds targeting carbonic anhydrases, key enzymes involved in various physiological processes. Her work spans the development of diverse chemical entities, including sulfonamide and non-sulfonamide derivatives, ureidosulfocoumarin derivatives, and indole-based hybrids. These compounds hold promise as potential inhibitors of specific isoforms of carbonic anhydrases, with implications for therapeutic intervention in conditions such as cancer and other diseases. Through innovative approaches and meticulous experimentation, Dr. Swain contributes to the advancement of medicinal chemistry, striving to unlock new avenues for drug discovery and development.

 

Publication Top Notes 
  1. “Design, synthesis, and biological evaluation of 3-benzenesulfonamide-linked 3-hydrazinoisatin derivatives as carbonic anhydrase inhibitors” (2024)
  2. “Design, Synthesis and Biological Assessment of Rhodanine-Linked Benzenesulfonamide Derivatives as Selective and Potent Human Carbonic Anhydrase Inhibitors” (2022) – cited by 1
  3. “Synthesis of a new series of quinoline/pyridine indole-3-sulfonamide hybrids as selective carbonic anhydrase IX inhibitors” (2022) – cited by 7
  4. “Efficient One-pot Synthesis of 3,3-di(indolyl)indolin-2-ones from Isatin and Indole Catalyzed by VOSO4 as Non-Sulfonamide Carbonic Anhydrase Inhibitors” (2022) – cited by 1
  5. “Exploration of 2-phenylquinoline-4-carboxamide linked benzene sulfonamide derivatives as isoform selective inhibitors of transmembrane human carbonic anhydrases” (2022) – cited by 6
  6. “Design and development of novel series of indole-3-sulfonamide ureido derivatives as selective carbonic anhydrase II inhibitors” (2022) – cited by 5
  7. “Design and synthesis of benzenesulfonamide-linked imidazo[2,1-b][1,3,4]thiadiazole derivatives as carbonic anhydrase I and II inhibitors” (2021) – cited by 6

 

 

 

Naglaa Ahmed | Pharmaceutical Organic chemistry Award | Women Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Naglaa Ahmed | Pharmaceutical Organic chemistry Award | Women Researcher Award

Assoc Prof Dr. Naglaa Ahmed, Faculty of pharmacy ,helwan university ,Cairo, Egypt

👩‍🔬 Dr. Naglaa Ahmed is an accomplished Associate Professor in Pharmaceutical Organic Chemistry at Helwan University, Egypt. With a PhD focused on synthesizing medicinal compounds, she has garnered recognition for her outstanding thesis. Her expertise extends to teaching and research, evident from her progression from Instructor to Associate Professor. Dr. Ahmed holds a Master’s degree and excels in computer skills, including an International Computer Driving License. She’s committed to advancing pharmaceutical sciences, exemplified by her numerous publications and presentations. A dedicated educator and researcher, Dr. Ahmed continues to inspire future generations in the field.

 

Publication Profile:

Scopus

Orcid

Google Scholar

Education
📚 Naglaa Mohamed Ahmed Abd Elaal achieved her B.Sc. degree with honors in Pharmaceutical Sciences from Helwan University in May 2002. She pursued her passion further, earning a Master’s degree in Pharmaceutical Organic Chemistry in November 2010, followed by a Doctor of Philosophy degree in the same field in October 2016, all from Helwan University.

Research Experience

🔬 Throughout her academic career, Naglaa has been actively involved in research, with notable contributions including her thesis on synthesizing thiouracil derivatives of medicinal value, for which she was awarded the prize for the best scientific thesis in the medicinal scientific field for the academic year 2016-2017 by Helwan University.

Research Focus

Dr. Naglaa Ahmed’s research primarily focuses on the design, synthesis, and biological evaluation of novel organic compounds with diverse pharmacological activities. She has contributed significantly to the fields of medicinal chemistry and drug discovery, with a particular emphasis on developing potential anticancer agents, antioxidants, antimicrobials, and anti-inflammatory compounds.

Publication Top Notes:

📚 Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors (Cited by: 53, 2020)
📚 Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma (Cited by: 47, 2019)
📚Novel indolyl-pyrimidine derivatives: synthesis, antimicrobial, and antioxidant evaluations (Cited by: 42, 2014)
📚 Synthesis and antimicrobial evaluation of some 6-aryl-5-cyano-2-thiouracil derivatives (Cited by: 32, 2011)
📚 Design, synthesis, molecular modeling and antitumor evaluation of novel indolyl-pyrimidine derivatives with EGFR inhibitory activity(Cited by: 29, 2021)
📚 Synthesis and antimicrobial activities of new indolyl-pyrimidine derivatives (Cited by: 27, 2011)
📚 Synthesis, antimicrobial, antioxidant activities of novel 6-aryl-5-cyano thiouracil derivatives (Cited by: 25, 2013)
📚 Anticancer activities of 6-aryl-5-cyano-2-thiouracil derivatives (Cited by: 15, 2012)
📚 Design, synthesis and biological evaluation of novel 2-thiouracil-5-sulfonamide isosteres as anticancer agents (Cited by: 9, 2018)
📚 Synthesis, molecular modelling, and biological evaluation of novel pyrimidine derivatives as anti-inflammatory agents (Cited by: 8, 2020)
📚 Synthesis and biological value of thiouracils and fused thiouracils (a review) (Cited by: 6, 2017)
📚 Synthesis, characterization and study of antimicrobial activity of some novel 5-cyano-2-thiouracil derivatives (Cited by: 6, 2014)
📚 Synthesis, anticancer activity, and molecular docking study of some novel 2-thiouracil sulfonamide derivatives (Cited by: 5, 2018)